UniProt ID | THUM1_HUMAN | |
---|---|---|
UniProt AC | Q9NXG2 | |
Protein Name | THUMP domain-containing protein 1 | |
Gene Name | THUMPD1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 353 | |
Subcellular Localization | ||
Protein Description | Functions as a tRNA-binding adapter to mediate NAT10-dependent tRNA acetylation. [PubMed: 25653167] | |
Protein Sequence | MAAPAQQTTQPGGGKRKGKAQYVLAKRARRCDAGGPRQLEPGLQGILITCNMNERKCVEEAYSLLNEYGDDMYGPEKFTDKDQQPSGSEGEDDDAEAALKKEVGDIKASTEMRLRRFQSVESGANNVVFIRTLGIEPEKLVHHILQDMYKTKKKKTRVILRMLPISGTCKAFLEDMKKYAETFLEPWFKAPNKGTFQIVYKSRNNSHVNREEVIRELAGIVCTLNSENKVDLTNPQYTVVVEIIKAVCCLSVVKDYMLFRKYNLQEVVKSPKDPSQLNSKQGNGKEAKLESADKSDQNNTAEGKNNQQVPENTEELGQTKPTSNPQVVNEGGAKPELASQATEGSKSNENDFS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAAPAQQTT ------CCCCCCCCC | 23.35 | 22814378 | |
8 | O-linked_Glycosylation | MAAPAQQTTQPGGGK CCCCCCCCCCCCCCC | 18.47 | 23301498 | |
9 | O-linked_Glycosylation | AAPAQQTTQPGGGKR CCCCCCCCCCCCCCC | 28.55 | 23301498 | |
15 | Acetylation | TTQPGGGKRKGKAQY CCCCCCCCCCCCHHH | 54.96 | 23749302 | |
15 | Ubiquitination | TTQPGGGKRKGKAQY CCCCCCCCCCCCHHH | 54.96 | - | |
22 | Phosphorylation | KRKGKAQYVLAKRAR CCCCCHHHEEHHHHH | 11.42 | 28796482 | |
26 | Acetylation | KAQYVLAKRARRCDA CHHHEEHHHHHHCCC | 42.29 | 25953088 | |
26 | Methylation | KAQYVLAKRARRCDA CHHHEEHHHHHHCCC | 42.29 | 91061 | |
26 | 2-Hydroxyisobutyrylation | KAQYVLAKRARRCDA CHHHEEHHHHHHCCC | 42.29 | - | |
49 | Phosphorylation | GLQGILITCNMNERK CCEEEEEECCCCHHH | 8.38 | - | |
79 | Phosphorylation | MYGPEKFTDKDQQPS CCCCCCCCCCCCCCC | 53.89 | 26503892 | |
86 | Phosphorylation | TDKDQQPSGSEGEDD CCCCCCCCCCCCCCC | 51.09 | 19664994 | |
88 | Phosphorylation | KDQQPSGSEGEDDDA CCCCCCCCCCCCCHH | 46.92 | 19664994 | |
109 | Phosphorylation | EVGDIKASTEMRLRR HHCCCCCCHHHHHHH | 21.65 | 28857561 | |
110 | Phosphorylation | VGDIKASTEMRLRRF HCCCCCCHHHHHHHH | 38.36 | 27251275 | |
119 | Phosphorylation | MRLRRFQSVESGANN HHHHHHHHHHCCCCC | 25.74 | 23898821 | |
122 | Phosphorylation | RRFQSVESGANNVVF HHHHHHHCCCCCEEE | 40.84 | 23312004 | |
177 | 2-Hydroxyisobutyrylation | KAFLEDMKKYAETFL HHHHHHHHHHHHHHH | 55.76 | - | |
178 | Ubiquitination | AFLEDMKKYAETFLE HHHHHHHHHHHHHHH | 42.95 | 21890473 | |
179 | Phosphorylation | FLEDMKKYAETFLEP HHHHHHHHHHHHHHH | 12.26 | - | |
182 | Phosphorylation | DMKKYAETFLEPWFK HHHHHHHHHHHHHHC | 25.91 | - | |
189 | Ubiquitination | TFLEPWFKAPNKGTF HHHHHHHCCCCCCEE | 60.09 | 21890473 | |
254 | Ubiquitination | VCCLSVVKDYMLFRK HHHHHHHHHHHHHHH | 40.77 | 21890473 | |
261 | Malonylation | KDYMLFRKYNLQEVV HHHHHHHHCCHHHHH | 31.02 | 26320211 | |
261 | 2-Hydroxyisobutyrylation | KDYMLFRKYNLQEVV HHHHHHHHCCHHHHH | 31.02 | - | |
262 | Phosphorylation | DYMLFRKYNLQEVVK HHHHHHHCCHHHHHC | 19.49 | 23312004 | |
269 | Malonylation | YNLQEVVKSPKDPSQ CCHHHHHCCCCCHHH | 67.24 | 26320211 | |
270 | Phosphorylation | NLQEVVKSPKDPSQL CHHHHHCCCCCHHHH | 26.10 | 23401153 | |
272 | Ubiquitination | QEVVKSPKDPSQLNS HHHHCCCCCHHHHCC | 84.83 | - | |
275 | Phosphorylation | VKSPKDPSQLNSKQG HCCCCCHHHHCCCCC | 58.39 | 30266825 | |
279 | Phosphorylation | KDPSQLNSKQGNGKE CCHHHHCCCCCCCCC | 34.64 | 30266825 | |
285 | Acetylation | NSKQGNGKEAKLESA CCCCCCCCCHHHHCC | 59.50 | 8276627 | |
288 | Acetylation | QGNGKEAKLESADKS CCCCCCHHHHCCCCC | 54.61 | 25953088 | |
294 | Acetylation | AKLESADKSDQNNTA HHHHCCCCCCCCCCC | 56.50 | 25953088 | |
295 | Phosphorylation | KLESADKSDQNNTAE HHHCCCCCCCCCCCC | 45.00 | 25159151 | |
300 | Phosphorylation | DKSDQNNTAEGKNNQ CCCCCCCCCCCCCCC | 33.37 | 28985074 | |
313 | Phosphorylation | NQQVPENTEELGQTK CCCCCCCHHHHCCCC | 29.22 | 23186163 | |
319 | Phosphorylation | NTEELGQTKPTSNPQ CHHHHCCCCCCCCCC | 36.87 | 23186163 | |
320 | Acetylation | TEELGQTKPTSNPQV HHHHCCCCCCCCCCC | 38.11 | 26051181 | |
322 | Phosphorylation | ELGQTKPTSNPQVVN HHCCCCCCCCCCCCC | 42.57 | 23186163 | |
322 | O-linked_Glycosylation | ELGQTKPTSNPQVVN HHCCCCCCCCCCCCC | 42.57 | OGP | |
323 | Phosphorylation | LGQTKPTSNPQVVNE HCCCCCCCCCCCCCC | 55.85 | 23186163 | |
334 | Acetylation | VVNEGGAKPELASQA CCCCCCCCHHHHHHH | 42.15 | 26051181 | |
339 | Phosphorylation | GAKPELASQATEGSK CCCHHHHHHHCCCCC | 32.73 | 25849741 | |
342 | Phosphorylation | PELASQATEGSKSNE HHHHHHHCCCCCCCC | 32.99 | 25159151 | |
345 | Phosphorylation | ASQATEGSKSNENDF HHHHCCCCCCCCCCC | 27.03 | 25849741 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of THUM1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of THUM1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of THUM1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
THUM3_HUMAN | THUMPD3 | physical | 22939629 | |
YAP1_HUMAN | YAP1 | physical | 22939629 | |
NP1L1_HUMAN | NAP1L1 | physical | 22863883 | |
2ABA_HUMAN | PPP2R2A | physical | 22863883 | |
DDX21_HUMAN | DDX21 | physical | 26186194 | |
NAT10_HUMAN | NAT10 | physical | 26186194 | |
FDXA1_HUMAN | FDXACB1 | physical | 26186194 | |
TRUA_HUMAN | PUS1 | physical | 26186194 | |
PUS7_HUMAN | PUS7 | physical | 26186194 | |
MTO1_HUMAN | MTO1 | physical | 26186194 | |
TGT_HUMAN | QTRT1 | physical | 26186194 | |
SYHC_HUMAN | HARS | physical | 26344197 | |
NDRG1_HUMAN | NDRG1 | physical | 26344197 | |
HNRPQ_HUMAN | SYNCRIP | physical | 26344197 | |
THUM3_HUMAN | THUMPD3 | physical | 26344197 | |
PUS7_HUMAN | PUS7 | physical | 28514442 | |
TGT_HUMAN | QTRT1 | physical | 28514442 | |
FDXA1_HUMAN | FDXACB1 | physical | 28514442 | |
NAT10_HUMAN | NAT10 | physical | 28514442 | |
TRUA_HUMAN | PUS1 | physical | 28514442 | |
YBOX1_HUMAN | YBX1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-86 AND SER-88, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-86 AND SER-88, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-86 AND SER-88, AND MASS SPECTROMETRY. | |
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-86 AND SER-88, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-86 AND SER-88, AND MASSSPECTROMETRY. | |
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment."; Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.; J. Proteome Res. 7:5167-5176(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-88, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-86 AND SER-88, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-86 AND SER-88, AND MASSSPECTROMETRY. |